208 related articles for article (PubMed ID: 8093103)
1. Interactions of some analogues of the anticonvulsant milacemide with monoamine oxidase.
O'Brien EM; Dostert P; Pevarello P; Tipton KF
Biochem Pharmacol; 1994 Aug; 48(5):905-14. PubMed ID: 8093103
[TBL] [Abstract][Full Text] [Related]
2. Species differences in the interactions of the anticonvulsant milacemide and some analogues with monoamine oxidase-B.
O'Brien EM; Dostert P; Tipton KF
Biochem Pharmacol; 1995 Jul; 50(3):317-24. PubMed ID: 7646533
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of monoamine oxidase B by analogues of the anticonvulsant agent milacemide (2-(n-pentylamino)acetamide).
Nishimura K; Lu X; Silverman RB
J Med Chem; 1993 Feb; 36(4):446-8. PubMed ID: 8474100
[TBL] [Abstract][Full Text] [Related]
4. The interactions of milacemide with monoamine oxidase.
O'Brien EM; Tipton KF; McCrodden JM; Youdim MB
Biochem Pharmacol; 1994 Feb; 47(4):617-23. PubMed ID: 8129740
[TBL] [Abstract][Full Text] [Related]
5. Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase B.
Janssens de Varebeke P; Cavalier R; David-Remacle M; Youdim MB
J Neurochem; 1988 Apr; 50(4):1011-6. PubMed ID: 3346666
[TBL] [Abstract][Full Text] [Related]
6. Is the oxidation of milacemide by monoamine oxidase a major factor in its anticonvulsant actions?
O'Brien EM; Tipton KF; Strolin Benedetti M; Bonsignori A; Marrari P; Dostert P
Biochem Pharmacol; 1991 Jun; 41(11):1731-7. PubMed ID: 2043162
[TBL] [Abstract][Full Text] [Related]
7. MAO activity, metabolism and anticonvulsant activity of milacemide in rats and mice.
Colombo M; Strolin Benedetti M; Bonsignori A; Cocchiara G; Roncucci R; Dostert P
J Neural Transm Suppl; 1990; 32():123-9. PubMed ID: 2089081
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
[TBL] [Abstract][Full Text] [Related]
9. The novel neuropsychotropic agent milacemide is a specific enzyme-activated inhibitor of brain monoamine oxidase B.
Janssens de Varebeke P; Pauwels G; Buyse C; David-Remacle M; De Mey J; Roba J; Youdim MB
J Neurochem; 1989 Oct; 53(4):1109-16. PubMed ID: 2769256
[TBL] [Abstract][Full Text] [Related]
10. Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases.
Bonaiuto E; Milelli A; Cozza G; Tumiatti V; Marchetti C; Agostinelli E; Fimognari C; Hrelia P; Minarini A; Di Paolo ML
Eur J Med Chem; 2013; 70():88-101. PubMed ID: 24140951
[TBL] [Abstract][Full Text] [Related]
11. Does FAD-dependent polyamine oxidase contribute to the metabolism of milacemide?
Strolin Benedetti M; Cocchiara G; Colombo M; Dostert P
J Neural Transm Suppl; 1990; 32():351-6. PubMed ID: 2128509
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
[TBL] [Abstract][Full Text] [Related]
13. N-alkyloxycarbonyl derivatives of ethylene diamine as monoamine oxidase inhibitors.
Pozdnev VF; Kirkel AZ; Kamyshanskaya NS; Axenova LN; Medvedev AE
J Neural Transm Suppl; 1998; 52():351-5. PubMed ID: 9564638
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of monoamine oxidase by pirlindole analogues: 3D-QSAR analysis.
Medvedev AE; Ramsay RR; Ivanov AS; Veselovsky AV; Shvedov VI; Tikhonova OV; Barradas AP; Davidson CK; Moskvitina TA; Fedotova OA; Axenova LN
Neurobiology (Bp); 1999; 7(2):151-8. PubMed ID: 10591049
[TBL] [Abstract][Full Text] [Related]
15. Monoamine oxidase inhibitory properties of milacemide in rats.
Truong DD; Diamond B; Pezzoli G; Mena MA; Fahn S
Life Sci; 1989; 44(15):1059-66. PubMed ID: 2784529
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of monoamine oxidase B by aminoethyl substituted benzyl ethers.
Woodroofe CC; Mostashari R; Lu X; Ramsay RR; Silverman RB
J Enzyme Inhib; 2000; 15(1):11-21. PubMed ID: 10850952
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 2-phenoxyacetamide analogues, a novel class of potent and selective monoamine oxidase inhibitors.
Shen W; Yu S; Zhang J; Jia W; Zhu Q
Molecules; 2014 Nov; 19(11):18620-31. PubMed ID: 25405283
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site.
Tripathi RKP; M Sasi V; Gupta SK; Krishnamurthy S; Ayyannan SR
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):37-57. PubMed ID: 29098902
[TBL] [Abstract][Full Text] [Related]
19. Some peculiar aspects of monoamine oxidase inhibition.
Ramadan ZB; Dostert P; Tipton KF
Neurobiology (Bp); 1999; 7(2):159-74. PubMed ID: 10591050
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of monoamine oxidase by 8-benzyloxycaffeine analogues.
Strydom B; Malan SF; Castagnoli N; Bergh JJ; Petzer JP
Bioorg Med Chem; 2010 Feb; 18(3):1018-28. PubMed ID: 20093036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
